Regulatory Convergence for Efficient Drug Approval
This session will focus on the importance of regulatory convergence and harmonization in streamlining the drug approval process and ensuring timely access to safe and effective medicines. It will address the challenges, benefits, and strategies for achieving regulatory convergence among different regulatory authorities worldwide. The session aims to foster collaboration and dialogue among regulatory agencies, pharmaceutical companies, and other stakeholders to enhance regulatory efficiency while maintaining rigorous safety and efficacy standards. Exploring approaches to enhance regulatory harmonization and streamline the drug approval process. Discussing the role of regulatory agencies, data sharing, and mutual recognition agreements. Addressing challenges and opportunities in ensuring safety, efficacy, and quality standards across different jurisdictions.
